European clinicians will have a new weapon to combat cervical cancer with the introduction of Abbott Molecular's real-time polymerase chain reaction (PCR) based diagnostic test for human ...

SEOUL, South Korea, July 16, 2024 /PRNewswire/ -- Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, demonstrated its human ...

BIRMINGHAM, Ala., Nov. 18, 2025 /PRNewswire/ -- Molecular Designs, a developer and manufacturer of molecular infectious-disease assays, today announced the launch of its Human Papillomavirus (HPV) ...

Human papillomavirus (HPV) infections are associated with the development of cervical neoplasia and are a necessary factor in the aetiology of cervical carcinoma (Walboomers et al, 1999; Bosch et al, ...

Human papillomavirus (HPV) is a DNA virus known to cause infections in mucous membranes and skin, typically resulting in warty lesions. While often benign, these lesions do have the potential to ...

Showcases Allplex™ HPV products designed to test for 14 high-risk HPV genotypes Advocates HPV testing for early diagnosis and prevention of cervical cancer Aims to accelerate the widespread adoption ...

- Aims to accelerate the widespread adoption of syndromic PCR testing to create "a world free from all diseases" SEOUL, South Korea, July 16, 2024 /PRNewswire/ -- Seegene Inc. (KQ096530), a leading ...

At the AOGIN, Seegene presented its advanced technologies for identifying viruses linked to cervical cancer. The company organized an exhibition booth and hosted a symposium session under the theme of ...